Clinical Trial Update: AntiPhospholipid Syndrome Low-molecular-weight Heparin Pregnancy Loss Evaluation: The Pilot Study [EARLY_Phase 1]

View source ↗

Summary

Pilot Phase 1 trial evaluating low-molecular-weight heparin for antiphospholipid syndrome in pregnancy; study terminated with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Antiphospholipid Syndrome in Pregnancy
• Pregnancy Loss

Snippet

Sponsor: Ottawa Hospital Research Institute | Conditions: Antiphospholipid Syndrome in Pregnancy, Pregnancy Loss | EARLY_Phase 1 | Status: TERMINATED | Results posted: 2020-04-08